Literature DB >> 30772587

For Whom is Hepatocellular Carcinoma Surveillance After Sustained Virologic Response Cost-Effective?

Amit G Singal1, George N Ioannou2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30772587      PMCID： PMC6661184          DOI： 10.1016/j.cgh.2019.02.020

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  18 in total

Review 1.  Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review.

Authors:  Amit G Singal; Adam Yopp; Celette S Skinner; Milton Packer; William M Lee; Jasmin A Tiro
Journal:  J Gen Intern Med       Date:  2012-01-04       Impact factor: 5.128

2.  Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States.

Authors:  Jessica A Davila; Robert O Morgan; Peter A Richardson; Xianglin L Du; Katherine A McGlynn; Hashem B El-Serag
Journal:  Hepatology       Date:  2010-07       Impact factor: 17.425

3.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Authors:  Laurent Castéra; Julien Vergniol; Juliette Foucher; Brigitte Le Bail; Elise Chanteloup; Maud Haaser; Monique Darriet; Patrice Couzigou; Victor De Lédinghen
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

4.  Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis.

Authors:  O Simmons; D T Fetzer; T Yokoo; J A Marrero; A Yopp; Y Kono; N D Parikh; T Browning; A G Singal
Journal:  Aliment Pharmacol Ther       Date:  2016-11-08       Impact factor: 8.171

5.  Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe.

Authors:  Robert P Myers; Gilles Pomier-Layrargues; Richard Kirsch; Aaron Pollett; Melanie Beaton; Mark Levstik; Andres Duarte-Rojo; David Wong; Pam Crotty; Magdy Elkashab
Journal:  J Hepatol       Date:  2011-10-23       Impact factor: 25.083

6.  Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma.

Authors:  Amit G Singal; Jasmin A Tiro; Jorge A Marrero; Katharine McCallister; Caroline Mejias; Brian Adamson; Wendy Pechero Bishop; Noel O Santini; Ethan A Halm
Journal:  Gastroenterology       Date:  2016-11-05       Impact factor: 22.682

7.  Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.

Authors:  Anna S Lok; Leonard B Seeff; Timothy R Morgan; Adrian M di Bisceglie; Richard K Sterling; Teresa M Curto; Gregory T Everson; Karen L Lindsay; William M Lee; Herbert L Bonkovsky; Jules L Dienstag; Marc G Ghany; Chihiro Morishima; Zachary D Goodman
Journal:  Gastroenterology       Date:  2008-09-18       Impact factor: 22.682

8.  Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

Authors:  Yujin Hoshida; Augusto Villanueva; Masahiro Kobayashi; Judit Peix; Derek Y Chiang; Amy Camargo; Supriya Gupta; Jamie Moore; Matthew J Wrobel; Jim Lerner; Michael Reich; Jennifer A Chan; Jonathan N Glickman; Kenji Ikeda; Masaji Hashimoto; Goro Watanabe; Maria G Daidone; Sasan Roayaie; Myron Schwartz; Swan Thung; Helga B Salvesen; Stacey Gabriel; Vincenzo Mazzaferro; Jordi Bruix; Scott L Friedman; Hiromitsu Kumada; Josep M Llovet; Todd R Golub
Journal:  N Engl J Med       Date:  2008-10-15       Impact factor: 91.245

9.  Machine learning algorithms outperform conventional regression models in predicting development of hepatocellular carcinoma.

Authors:  Amit G Singal; Ashin Mukherjee; B Joseph Elmunzer; Peter D R Higgins; Anna S Lok; Ji Zhu; Jorge A Marrero; Akbar K Waljee
Journal:  Am J Gastroenterol       Date:  2013-10-29       Impact factor: 10.864

10.  Cost-Effectiveness of Risk Score-Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis.

Authors:  Nicolas Goossens; Amit G Singal; Lindsay Y King; Karin L Andersson; Bryan C Fuchs; Cecilia Besa; Bachir Taouli; Raymond T Chung; Yujin Hoshida
Journal:  Clin Transl Gastroenterol       Date:  2017-06-22       Impact factor: 4.396
View more
  2 in total

1.  Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores.

Authors:  George N Ioannou; Lauren A Beste; Pamela K Green; Amit G Singal; Elliot B Tapper; Akbar K Waljee; Richard K Sterling; Jordan J Feld; David E Kaplan; Tamar H Taddei; Kristin Berry
Journal:  Gastroenterology       Date:  2019-07-26       Impact factor: 22.682

2.  Assessment of Incidence of and Surveillance Burden for Hepatocellular Carcinoma Among Patients With Hepatitis C in the Era of Direct-Acting Antiviral Agents.

Authors:  Qiushi Chen; Turgay Ayer; Madeline G Adee; Xiaojie Wang; Fasiha Kanwal; Jagpreet Chhatwal
Journal:  JAMA Netw Open       Date:  2020-11-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.